QSI
Quantum-Si incorporated
NASDAQ · Healthcare · Biotechnology · US
$0.77
+1.18%Year over year
Reported trailing growth
- Revenue
- -53.0%
- EBITDA
- +13.5%
- EBIT
- +14.0%
- EPS
- +31.7%
- Free cash flow
- +2.8%
- Operating cash flow
- -0.1%
Forward estimates
Based on analyst estimates
- Revenue
- +26.5%
- EBITDA
- -0.3%
- EPS
- +4.5%
Three-year CAGR
- Revenue
- +50.0%
- EBITDA
- +3.6%
- EBIT
- +10.3%
- Net income
- -0.3%
- EPS
- +28.2%
- Free cash flow
- -5.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026